SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION

There is no standard therapy for multiple myeloma (MM) relapsing after an autotransplant. We compared the outcomes of a 2(nd) autotransplant (N=137) with those of an allotransplant (N=152) after non-myeloablative or reduced-intensity conditioning (NST/RIC) in 289 subjects reported to the CIBMTR from...

Descripción completa

Detalles Bibliográficos
Autores principales: Freytes, Cesar O., Vesole, David H., LeRademacher, Jennifer, Zhong, Xiaobo, Gale, Robert Peter, Kyle, Robert A., Reece, Donna E., Gibson, John, Schouten, Harry C., McCarthy, Philip L., Lonial, Sagar, Krishnan, Amrita Y., Dispenzieri, Angela, Hari, Parameswaran N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947725/
https://www.ncbi.nlm.nih.gov/pubmed/24270389
http://dx.doi.org/10.1038/bmt.2013.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947725/
https://www.ncbi.nlm.nih.gov/pubmed/24270389
http://dx.doi.org/10.1038/bmt.2013.187

Ejemplares similares